Phase III study of valspodar (PSC 833) combined with paclitaxel and carboplatin compared with paclitaxel and carboplatin alone in patients with stage IV or suboptimally debulked stage III epithelial ovarian cancer or primary peritoneal cancer (Q81351655)
scientific article published on 01 June 2008
Language:
(P31) (Q13442814)
(P304) 2674-2682
(P407) (Q1860)
(P433) 16
(P478) 26
(P577) Sunday, June 1, 2008
(P921) (Q172341)
(Q423762)
(Q415588)
(P1433) (Q400292)
(P1476) "Phase III study of valspodar (PSC 833) combined with paclitaxel and carboplatin compared with paclitaxel and carboplatin alone in patients with stage IV or suboptimally debulked stage III epithelial ovarian cancer or primary peritoneal cancer" (language: en)
(P2093) Catherine Lhommé
Florence Joly
Joan L Walker
Andrea A Lissoni
Maria O Nicoletto
Gregory M Manikhas
Mark M O Baekelandt
Alan N Gordon
Paula M Fracasso
William L Mietlowski
Gary J Jones
Margaret H Dugan
other details
description scientific article published on 01 June 2008

External Links